Eldridge George A's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Mar 14, 2024
- Accession no.
- 0001415889-24-008033
- Filed
- Mar 14, 2024
- Trade date
- Mar 12-13, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $101.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eldridge George ACIK 0001413006 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Common Stock | MOption exerciseAcquired | +2,051 | $2.14 | +$4,389.14 | 4,011 | Direct | |
| Mar 12, 2024 | Common Stock | SSaleDisposed | −2,051 | $25.05 | −$51,377.55 | 1,960 | Direct | |
| Mar 13, 2024 | Common Stock | MOption exerciseAcquired | +2,016 | $2.14 | +$4,314.24 | 3,976 | Direct | |
| Mar 13, 2024 | Common Stock | SSaleDisposed | −2,016 | $25.02 | −$50,440.32 | 1,960 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Common Stock | MOption exerciseDisposed | −2,051 | $0.00 | $0 | 53,279 | Direct | |
| Mar 13, 2024 | Common Stock | MOption exerciseDisposed | −2,016 | $0.00 | $0 | 51,263 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.